CINECA IRIS Institutional Research Information System

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 167
Titolo Data di pubblicazione Autore(i) File
Unsymmetrically substituted furoxans. Part 18. Smiles rearrangement in furoxan systems and in related furazans 2001 D. BOSCHI; G. SORBA; M. BERTINARIA; R. FRUTTERO; R. CALVINO; A. GASCO
Studies on Agents with Mixed NO-Dependent and Calcium Channel Antagonistic Vasodilating Activities. 2001 C. CENA; VISENTIN S.; DI STILO A.; BOSCHI D.; FRUTTERO R.; GASCO A.
Activity of calvatic acid and its analogs against Helicobacter pylori 2001 BOSCHI D.; C. CENA; FRUTTERO R.; BRENCIAGLIA M. I.; SCALTRITO M. M.; DUBINI F.; GASCO A.
Searching for Balanced Hybrid NO-Donor 1,4-Dihydropyridines with Basic Properties 2001 BOSCHI D.; G. CARON; VISENTIN S.; DI STILO A.; ROLANDO B.; FRUTTERO R.; GASCO A.
Thermolysis of 4-(2-azido-3-nitrophenyl)-1,4-dihydropyridines as source of beta-carboline derivatives and some related compounds 2001 S. Visentin; G. Ermondi; D. Boschi; G. Grosa; R. Fruttero; A. Gasco
New Uroselective NO-Donor a1-antagonists 2002 A. DI STILO; D. BOSCHI; E. MARINI; R. FRUTTERO; A. GASCO
New Selective COX-2 Inhibitors 2003 D. BOSCHI; CLARA CENA; ERIKA DEL GROSSO; STEFANO MORO; ALBERTO GASCO
New potential uroselective NO-donor a1-antagonists 2003 D. BOSCHI; TRON G.C.; DI STILO A.; FRUTTERO R.; GASCO A.; POGGESI E.; MOTTA G.; LEONARDI A.
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants 2004 C. CENA; D. BOSCHI; G.C. TRON; K. CHEGAEV; L. LAZZARATO; A. DI STILO; M. ARAGNO; R. FRUTTERO; A. GASCO
Use of the furoxan (1,2,5-oxadiazole 2-oxide)system in the design of new NO-donor antioxidant hybrids 2005 C. CENA; M. BERTINARIA; D. BOSCHI; M. GIORGIS; A. GASCO
The Furoxan System: Design of Selective Nitric Oxide (NO) Donor Inhibitors of COX-2 Endowed with Anti-Aggregatory and Vasodilating Activities 2005 DEL GROSSO E.; BOSCHI D.; LAZZARATO L.; CENA C.; DI STILO A.; FRUTTERO R.; MORO S.; GASCO A.
Use of the furoxan (1,2,5-oxadiazole 2-oxide) system in the design of new NO-donor antioxidant hybrids 2006 C. CENA; M. BERTINARIA; D. BOSCHI; M. GIORGIS; A. GASCO
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties 2006 D. BOSCHI; G.C. TRON; L. LAZZARATO; K. CHEGAEV; C. CENA; A. DI STILO; M. GIORGIS; M. BERTINARIA; R. FRUTTERO; A. GASCO
Nitrooxymethyl substituted analogues of Celecoxib and Rofecoxib 2007 BOSCHI D; CENA C; LAZZARATO L; MARINI E; FRUTTERO R.; GASCO A.
Synthesis and Antimicrobial Activity of New 1,5-Dimethyl-3-Heteroaryl-1H-4-ONN-Azoxycyanides 2008 Stefania Aiello; Enrico Aiello; Angela Provino; Donatella Boschi; Maria La Francesca
Nitrooxymethyl substituted analogues of celecoxib as potential antitumoral drugs with reduced cardiotoxicity 2008 Boschi D; Lazzarato L; Filieri A; Miglietta A; Bocca C; Fruttero R; Gasco A.
Multitarget Drugs: Focus on the NO-donor hybrid drugs 2008 Alberto Gasco; Donatella Boschi; Konstantin Chegaev; Clara Cena; Antonella Di Stilo; Roberta Fruttero; Loretta Lazzarato; Barbara Rolando; Paolo Tosco
Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth 2009 Bozzo F; Bassignana A; Lazzarato L; Boschi D; Gasco A; Bocca C; Miglietta A.
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization 2009 Donatella Boschi; Loretta Lazzarato; Barbara Rolando; Andrea Filieri; Clara Cena; Antonella Di Stilo; Roberta Fruttero; Alberto Gasco
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors 2010 Roberta Fruttero; Loretta Lazzarato; Konstantin Chegaev; Barbara Rolando; Donatella Boschi; Claudiu T. Supuran; Alessio Innocenti; Alberto Gasco
Mostrati risultati da 21 a 40 di 167
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile